Richard Narido
Director of Finance/CFO at NRX PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-05-30
Richard Narido active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NRX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2023-09-12 | - |
| Director of Finance/CFO | 2023-09-12 | - |
Career history of Richard Narido
Former positions of Richard Narido
| Companies | Position | Start | End |
|---|---|---|---|
| LUCIRA HEALTH, INC. | Comptroller/Controller/Auditor | 2022-11-14 | - |
| Director of Finance/CFO | 2022-11-14 | 2023-03-31 | |
| Corporate Officer/Principal | 2021-02-28 | - | |
| ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 2018-06-30 | 2021-02-28 |
| Director of Finance/CFO | 2018-06-30 | 2021-02-28 | |
| Treasurer | 2018-06-30 | 2021-02-28 | |
| BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 2014-05-31 | 2018-05-31 |
| MCKESSON CORPORATION | Corporate Officer/Principal | 2005-12-31 | 2010-10-31 |
Training of Richard Narido
| University of San Francisco | Undergraduate Degree |
| Pepperdine Graziadio Business School | Graduate Degree |
Statistics
International
| United States | 7 |
| 2 |
Operational
| Director of Finance/CFO | 3 |
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| NRX PHARMACEUTICALS, INC. | Health Technology |
| BIO-RAD LABORATORIES, INC. | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| MCKESSON CORPORATION | Distribution Services |
| Private companies | 1 |
|---|---|
Lucira Health, Inc.
 Lucira Health, Inc. Medical SpecialtiesHealth Technology Lucira Health, Inc. is a medical technology company, which engages in the business of developing and commercializing transformative and innovative infectious disease test kits. It operates through the following customer segments: the United States Healthcare (US Healthcare), United States Business to Business and Government (US Business to Business and Government), Direct to Consumer (DTC), and International. The US Healthcare segment provides solutions of choice for certain telehealth platforms and providers who are able to confirm diagnosis immediately and over a telehealth platform to drive treatment. The US Business to Business and Government segment is involved in selling OTC test kits to both employers and government organizations. The DTC segment includes selling directly to the individual consumer through online platforms. The International segment focuses on selling tests into Canada, Taiwan, Singapore, and Israel. The company was founded by Debkishore Mitra, John Robert Waldeisen, and Benjamin Ross on February 20, 2013 and is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- Richard Narido
- Experience
